About us

Our vision

What we strive for.

Envisioning a Brighter Horizon: Guided by our unwavering commitment to excellence, we are poised to revolutionize the landscape of plasma protein therapies. With unparalleled capabilities and a track record of remarkable results, we stand at the forefront of innovation, dedicated to reshaping the future of plasma protein therapies.

Our resources

Deliver results. At speed.

Diverse know-how plus solid resource inventory allows PreviPharma the ability to deliver results at a speed and skill unprecedented within the industry. Supporting virtually all industry players, PreviPharma helps its clients accelerate R&D across the entire product life-cycle.

34 highly skilled team members

300 sqm space for pilot Mfg (2024)

450 sqm lab space with specialized equipment

Network of qualified scientific and clinical research partners

GLP/GMP capabilities

A strong partner for groundbreaking innovations

Wide industry coverage

18 families patent

6 preclinical assets

Our management

Led by experience.

Marc Mazur

Marc Mazur

Founder, CEO and Owner

  • 15 years of experience in plasma industry
  • 10+ years management consulting
Dr. Satish Deverapu, PhD

Dr. Satish Deverapu, PhD

Chief Scientific Officer (CSO)

  • 15 years of R&D experience in academia
  • 5 years experience in plasma industry at Director level
Stephan T. Kiessig, MD, PhD

Stephan T. Kiessig, MD, PhD

Chief Medical Officer (CMO)


  • 27 years in plasma industry, including 10 years with a leading plasma fractionator,
  • 10 years C-level experience
    >200 publications
Tanja Wilke

Tanja Wilke

Director of Finance

  • 25 years of financel and tax experience in various managerial positions for midsize companies in Germany

Get in touch with us

We are pleased to provide you more information and discuss the possibilities of a cooperation.